• Sonuç bulunamadı

Activation of c-jun NH2-terminal kinase and subsequent CPP32/Yama during topoisomerase inhibitor -lapachone-induced apoptosis through an oxidation-dependent pathway.

N/A
N/A
Protected

Academic year: 2021

Share "Activation of c-jun NH2-terminal kinase and subsequent CPP32/Yama during topoisomerase inhibitor -lapachone-induced apoptosis through an oxidation-dependent pathway."

Copied!
1
0
0

Yükleniyor.... (view fulltext now)

Tam metin

(1)

Activation of c-jun NH2-terminal kinase and

subsequent CPP32/Yama during topoisomerase

inhibitor -lapachone-induced apoptosis through an

oxidation-dependent pathway.

沈杏娟

Shiah GS;Chuang SE;Chau YP;Shen SC and Kuo ML

Abstract

ß-Lapachone (ß-Lap) has been found to inhibit DNA topoisomerases (Topos) by a mechanism distinct from that of other commonly known Topo inhibitors. Here, we demonstrated a pronounced elevation of H2O2 and O2- in human leukemia HL-60 cells treated with ß-Lap. Treatment with other Topo poisons, such as camptothecin (CPT), VP-16, and GL331, did not have the same effect. On the other hand, antioxidant vitamin C (Vit C) treatment effectively antagonized ß-Lap-induced apoptosis. This suggested that a reactive oxygen species (ROS)-related pathway was involved in ß-Lap-induced apoptosis program. We also found that c-Jun NH2-terminal kinase (JNK) but not p38 mitogen-activated protein kinase or extracellular signal-regulated kinase 1/2 was persistently activated in apoptosis induced by ß-Lap. Overexpression of a dominant-negative mutant

mitogen-activated protein kinase kinase kinase 1 (MEKK1-DN) or treatment with JNK-specific antisense oligonucleotide or Vit C all prevented ß-Lap-induced JNK activation and the subsequent apoptosis. Only the expression of MEKK1-DN, not Vit C treatment, blocked the JNK activity induced by CPT, VP-16, or GL331. These results confirm again that ROS acts as a mediator for JNK activation during ß-Lap-induced apoptosis. Furthermore, we found that ß-Lap can stimulate CPP32/Yama activity, which was, however, markedly inhibited by the MEKK1-DN expression or Vit C treatment. Again, CPT-induced CPP32/Yama activation can be abolished by MEKK1-DN but not by Vit C treatment. Taken together, these results indicate that ß-Lap but not other Topo inhibitors triggers apoptosis signaling, i.e., JNK and subsequent CPP32/Yama activation are mediated by the generation of ROS.

Referanslar

Benzer Belgeler

In addition, PKC inhibitor GF-109203X treatment blocks TPA- induced ERKs and JNKs protein phosphorylation, which indicates that activation of PKC locates at

TPA addition induces the phosphorylation of JNKs and ERKs, but not p38, protein in HL-60 cells, and incubation of HL-60 cells with JNKs inhibitor SP600125, but not ERKs inhibitor,

TPA addition in- duces the phosphorylation of JNKs and ERKs, but not p38, protein in HL-60 cells, and incubation of HL-60 cells with JNKs inhibitor SP600125, but not ERKs

Simülasyonla, Mamdani ve Larsen tip bulanık içermelerin aynı nokta ve aynı açıda karşılaştırılması Şekil 4.8(a) ve 4.8(b)’de, ayrıca, bu iki bulanık

Methods: After rats received a plantar incision surgery, mechanical allodynia and thermal hyperalgesia were determined by von Frey filaments and radiant heat, respectively, and

We provide evidence that the Jun N-terminal kinase (JNK) signaling pathway mediates Aβ- and ceramide-induced apoptosis: Both Aβ and ceramide activated JNK phosphorylation,

Denbinobin-induced cell apoptosis was attenuated by an ASK1 dominant-negative mutant (ASK1DN), two antioxidants (N-acetyl-L-cysteine (NAC) and glutathione (GSH)), a c-Jun

To further examine the role of phosphorylation in HDAg function, two conservative CKII recognition sites at Ser-2 and Ser-123 of both HDAgs and one potential PKC recognition site